Epsilon M&A Deal Report - Cyto Obwegeser
Transaction Multiples for the Valuation of Private Companies
Lab Top Medizinische Laboratorien / Cyto Obwegeser
No EMAT :
64979
Announced Date :
12/02/2014
Type :
Acquisition of Majority Stake
Deal Value :
Yes
Acquirer :
Lab Top Medizinische Laboratorien
Target :
Cyto Obwegeser
Country :
Switzerland
Sector of activity :
- Laboratories > Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Medical Diagnostic Laboratory
Business Description :
Cyto Obwegeser AG operates as a gynecological diseases drugs developer , in particular diseases of the womb (uterus, cervix), the sg Gynecological cytology as well as in breast disease (breast...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
|||||||
| Current |
Rating :
*
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Medical Diagnostic Laboratory » = 55
| Date | Acquirer | Target | Country | Multiples | See details |
| 02/06/2014 | Private Group led by Astorg Partners and Montagu Private Equity | Sebia | France | * | 64974 |
| 09/04/2014 | Private Group led by LBO Partners | Menix | France | * | 64965 |
Source: Epsilon Research / EMAT
